Answer
Donanemab infusion-related reactions may cause erythema, chills, nausea, vomiting, sweating, headache, chest tightness, dyspnoea and blood-pressure changes, and may include severe or life-threatening anaphylaxis.
Sources for this answer
- Kisunla 350 mg concentrate for solution for infusionEli Lilly and Company Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 3Document updated
Sources checked